TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32032651

Group type: EXPERIMENTAL
Intervention: TTM at 33°C
Number of subjects: 696

Group type: COMPARATOR
Intervention: TTM at 36°C
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (after correction for confounders)
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (after correction for clustering within centers)
Number of subjects: 696
Study: 35980349

Group type: COMPARATOR
Intervention: Nivolumab
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Nivolumab + Docetaxel
Number of subjects: 128
Study: 32821924

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 1317

Group type: COMPARATOR
Intervention: Non-caloric restriction (non-CR)
Number of subjects: 1317
Study: 36108767

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine combined with insulin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: COMPARATOR
Intervention: DM group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Insulin monotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: NAC monotherapy
Number of subjects: 40
Study: 34245368

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (0.1 mg/kg in 100 ml normal saline)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (100 ml normal saline)
Number of subjects: 76
Study: 34157772

Group type: EXPERIMENTAL
Intervention: Mozart's double piano sonata exposure for 14 days, twice per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: No music exposure (control group)
Number of subjects: 40
Study: 33046607

Group type: EXPERIMENTAL
Intervention: Multistrain probiotics capsules (n = 34)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (n = 38)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fecal calprotectin levels
Number of subjects: 72
Study: 33138121

Group type: EXPERIMENTAL
Intervention: Powdered milk
Number of subjects: 3864

Group type: EXPERIMENTAL
Intervention: Young children milk (YCM) for ages 1-2 years and preschool children milk (PCM) for ages 3-5 years
Number of subjects: 3864

Group type: EXPERIMENTAL
Intervention: Both scenarios (Powdered milk and YCM/PCM)
Number of subjects: 3864
Study: 34018138

Group type: EXPERIMENTAL
Intervention: Active intervention focusing on reducing caloric intake and increasing steps across the day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 28
Study: 32568139

Group type: EXPERIMENTAL
Intervention: 30 minutes of moderate-intensity cycling exercise
Number of subjects: 27

Group type: COMPARATOR
Intervention: 40-minute rest (control group)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Comparison of RHI before exercise between groups
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Comparison of RHI after exercise between groups
Number of subjects: 27
Study: 33259163

Group type: EXPERIMENTAL
Intervention: Acid suppression plus feeding modifications (4 weeks' proton pump inhibitor [PPI] + feeding modifications)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Acid suppression alone (4 weeks' proton pump inhibitor [PPI])
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both treatment groups (PPI + feeding modifications and PPI alone)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Infants with PPI washout
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Infants with continued PPI therapy
Number of subjects: 49
Study: 35351537

Group type: EXPERIMENTAL
Intervention: Distance-guided deep learning method for dose prediction
Number of subjects: 161

Group type: COMPARATOR
Intervention: Mask-based methods
Number of subjects: 161
Study: 35192209

Group type: EXPERIMENTAL
Intervention: FX CorAL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ELISIO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: xevonta
Number of subjects: 0
Study: 33068707

Group type: EXPERIMENTAL
Intervention: BReF intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 24
Study: 33800650

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 13
Study: 32583982

Group type: COMPARATOR
Intervention: Vitamin D supplementation
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Marine Omega-3 Fatty Acid supplementation
Number of subjects: 1398
Study: 34817631

Group type: EXPERIMENTAL
Intervention: Capsulorrhaphy performed (Group A)
Number of subjects: 67

Group type: COMPARATOR
Intervention: No capsulorrhaphy performed (Group B)
Number of subjects: 67
Study: 33091520

Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell (BM MNC) therapy, 200 million BM MNC's injected transendocardially after a 60 mL bone marrow aspiration.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell (BM MNC) therapy
Number of subjects: 10
Study: 33087156

Group type: EXPERIMENTAL
Intervention: Data-driven implementation strategies
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no data-driven implementation strategies)
Number of subjects: 12
Study: 34972033

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (0.5 μg/kg/min over 20 min)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride over 20 min)
Number of subjects: 33
Study: 34181008

Group type: EXPERIMENTAL
Intervention: Neighborhoods with greater deprivation
Number of subjects: 97

Group type: COMPARATOR
Intervention: Neighborhoods with lesser deprivation
Number of subjects: 97
Study: 32145277

Group type: EXPERIMENTAL
Intervention: Bilateral arm training
Number of subjects: 69

Group type: COMPARATOR
Intervention: Unilateral arm training
Number of subjects: 69
Study: 616280573

Group type: EXPERIMENTAL
Intervention: Enhanced Transtheoretical Model Intervention (ETMI)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Physiotherapy as usual (Control)
Number of subjects: 220
Study: 36029019

Group type: COMPARATOR
Intervention: Screening for cardiovascular disease using low-dose computed tomography, limb blood pressure measurement, telemetric assessment of heart rhythm, cholesterol and HgbA1c measurements.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No screening (control group)
Number of subjects: 0
Study: 33974564

Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cells (MSCs)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Airspace Ang-2
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Airspace receptor for advanced glycation end-products (RAGE)
Number of subjects: 27
Study: 33322192

Group type: EXPERIMENTAL
Intervention: Latanoprost once a day
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Combined preparation of brimonidine and timolol BID
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no topical hypotensive treatment)
Number of subjects: 86
Study: 35082139

Group type: EXPERIMENTAL
Intervention: Vitamin D (2000 IU/day)
Number of subjects: 25871

Group type: EXPERIMENTAL
Intervention: Omega 3 fatty acids (1000 mg/day)
Number of subjects: 25871

Group type: EXPERIMENTAL
Intervention: Vitamin D and omega 3 fatty acids
Number of subjects: 25871

Group type: EXPERIMENTAL
Intervention: Only Vitamin D
Number of subjects: 25871

Group type: EXPERIMENTAL
Intervention: Only Omega 3 fatty acids
Number of subjects: 25871

Group type: COMPARATOR
Intervention: Vitamin D placebo and omega 3 fatty acid placebo
Number of subjects: 25871
Study: 33638016

Group type: EXPERIMENTAL
Intervention: Vibration foam roll (VFR)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-vibration foam roll (NVFR)
Number of subjects: 21
Study: 35242500

Group type: EXPERIMENTAL
Intervention: 12-month lifestyle intervention (interactive web-based behavioral intervention)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-PE control group
Number of subjects: 300
Study: 33652763

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (Lactobacillus, Bifidobacterium, and Streptococcus thermophilus) for eight weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for eight weeks
Number of subjects: 0
Study: 35744008

Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionated whole-breast 3D conformal radiotherapy of 26 Gy in 5 fractions over 1 week
Number of subjects: 60
Study: 34559956

Group type: EXPERIMENTAL
Intervention: LCP-Tac
Number of subjects: 9

Group type: COMPARATOR
Intervention: PR-Tac
Number of subjects: 9
Study: 35848770

Group type: EXPERIMENTAL
Intervention: 3D virtual reality models for surgical planning
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 3D virtual reality models for surgical planning (subset with modified operative plan)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual preoperative planning with prostate biopsy results and MRI only (Control)
Number of subjects: 92
Study: 32325006

Group type: EXPERIMENTAL
Intervention: Instagram posts regarding antidepressant use
Number of subjects: 13096

Group type: EXPERIMENTAL
Intervention: Posts mentioning psychotherapy, comorbidities, or polypharmacy
Number of subjects: 13096

Group type: EXPERIMENTAL
Intervention: Instagram posts overall
Number of subjects: 13096
Study: 32077729

Group type: EXPERIMENTAL
Intervention: Tuning in to Teens (TINT) program, a 6-session intervention targeting parent emotion awareness/regulation, parental beliefs about emotion, and parents' emotion coaching skills.
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control condition (not specified in detail).
Number of subjects: 225
Study: 36505196

Group type: EXPERIMENTAL
Intervention: C-MAC video-laryngoscope
Number of subjects: 150

Group type: COMPARATOR
Intervention: Miller laryngoscope
Number of subjects: 150
Study: 34732660

Group type: EXPERIMENTAL
Intervention: Combination treatment (COM) - MET 500 mg TID, exenatide 2 mg QW
Number of subjects: 50

Group type: COMPARATOR
Intervention: Metformin (MET) - 500 mg three times a day (TID)
Number of subjects: 50
Study: 34525105

Group type: EXPERIMENTAL
Intervention: Online Life Story Book (OLSB) intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait list control condition
Number of subjects: 42
Study: 33292973

Group type: EXPERIMENTAL
Intervention: Bacterial phytase supplementation
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Fungal phytase supplementation
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Phytase dosages (450 and 900 FTU)
Number of subjects: 270
Study: 35149642

Group type: EXPERIMENTAL
Intervention: Interactive Spaced Education (ISE/QI)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard Education (STD/QI)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 101
Study: 33621804

Group type: EXPERIMENTAL
Intervention: MPS-PWUD scale (9-item scale with two components)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Enacted stigma (6 items)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Internalized stigma (3 items)
Number of subjects: 164
Study: 32880847

Group type: EXPERIMENTAL
Intervention: Local Vibration (LV) - frequency 80 Hz; amplitude 1 mm
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Local Vibration (LV)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Whole-body Vibration (WBV) - frequency 30 Hz; amplitude 2 mm
Number of subjects: 21
Study: 35103951

Group type: EXPERIMENTAL
Intervention: Faster insulin aspart (FIA)
Number of subjects: 117
Study: 34959919

Group type: EXPERIMENTAL
Intervention: Graphic beverage health warning labels
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Beverage sugar content information
Number of subjects: 262

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 262
Study: 33463052

Group type: EXPERIMENTAL
Intervention: PSORI-CM01
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 35362766

Group type: EXPERIMENTAL
Intervention: Salmon fish protein supplement
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 33691517

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (2–4 mg/day)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (in open-label study)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 381
Study: 32716303

Group type: EXPERIMENTAL
Intervention: mHealth app intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine health care and instruction
Number of subjects: 100
Study: 35728840

Group type: COMPARATOR
Intervention: Perineural dexamethasone (2 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Combined perineural dexamethasone (2 mg)‐dexmedetomidine (50 µg)
Number of subjects: 50
Study: 34776182

Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (AL-TENS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conventional TENS (C-TENS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham TENS (S-TENS)
Number of subjects: 60
Study: 32518042

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg once daily
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg once daily
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study: 35181846

Group type: EXPERIMENTAL
Intervention: BVERS only
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: BVERS + PC
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 14
Study: 33604690

Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE (27.5 GBq cumulative activity divided in five cycles of 5.5 GBq each every 8 weeks) plus metronomic capecitabine (1000–1500 mg daily during inter-cycle period)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE plus metronomic capecitabine
Number of subjects: 37
Study: 36127094

Group type: EXPERIMENTAL
Intervention: TEMPiS-Flying Intervention Team (TEMPiS-FIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 33645407

Group type: EXPERIMENTAL
Intervention: 28-compartment pillbox
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (no pillbox)
Number of subjects: 190
Study: 34930790

Group type: EXPERIMENTAL
Intervention: Pharmacy-led intervention (two personalised sessions addressing negative treatment beliefs and action planning)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study: 34342019

Group type: EXPERIMENTAL
Intervention: Small for gestational age (SGA)
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Fetal alcohol syndrome (FAS)
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Partial FAS
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Alcohol-related neurodevelopmental disorder
Number of subjects: 737

Group type: COMPARATOR
Intervention: Preterm birth
Number of subjects: 737

Group type: COMPARATOR
Intervention: Both preterm and SGA
Number of subjects: 737
Study: 36329227

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (60,000 IU weekly followed by 5000 IU daily)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 110
Study: 34090255

Group type: EXPERIMENTAL
Intervention: IV ketamine
Number of subjects: 56

Group type: COMPARATOR
Intervention: IV midazolam (placebo)
Number of subjects: 56
Study: 32842722

Group type: EXPERIMENTAL
Intervention: Femoral nerve block with 2% chloroprocaine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline sham (control)
Number of subjects: 16
Study: 35066133

Group type: EXPERIMENTAL
Intervention: Riboflavin Photosensitizer (RF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Silver Diamine Fluoride (SDF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Photon Induced Photoacoustic Streaming (PIPS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diode Laser
Number of subjects: 40
Study: 34536993

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral superficial cervical plexus block (BSCPB) with 7.5 ml of ropivacaine 0.5% on each side
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (CON) with equal amount of 0.9% normal saline
Number of subjects: 82
Study: 35807888

Group type: EXPERIMENTAL
Intervention: Mother's Own Milk with fortification (F-MOM)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Mother's Own Milk without fortification (U-MOM)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Preterm Formula (PF-group)
Number of subjects: 214
Study: 33904275

Group type: EXPERIMENTAL
Intervention: Radiation doses
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: T classification
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Mandibular surgery
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Periodontitis
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Tooth extraction after radiotherapy
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Dental caries
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Periapical periodontitis
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Unilateral/bilateral radiotherapy
Number of subjects: 757
Study: 32933552

Group type: EXPERIMENTAL
Intervention: Licorice-based herbal preparation (D-Reglis ®) at a dose of 760 mg three times a day for seven days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard treatment for COVID-19 based on the Iranian Ministry of Health and Medical Education's protocol for seven days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Licorice-based herbal preparation (D-Reglis ®)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard treatment for COVID-19
Number of subjects: 60
Study: 35202848

Group type: EXPERIMENTAL
Intervention: Metformin (25mg/cat PO/q24h for 30 days)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Obesity and diabetes mellitus (O&D) adjuvant diet (Equilíbrio O&D, Total Alimentos ADM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Methylprednisolone acetate (20 mg intramuscularly)
Number of subjects: 28
Study: 33137161

Group type: EXPERIMENTAL
Intervention: Ramelteon (8 mg/day on the day before surgery and on postoperative days 1 to 3)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control (no ramelteon administration)
Number of subjects: 306
Study: 35977836

Group type: EXPERIMENTAL
Intervention: ubrogepant 50 mg
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: ubrogepant 100 mg
Number of subjects: 808

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 808
Study: 33458787

Group type: EXPERIMENTAL
Intervention: Aligner
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 117
Study: 35295331

Group type: COMPARATOR
Intervention: Carbocysteine oral solution (mint taste)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Carbocysteine oral solution (strawberry taste)
Number of subjects: 42
Study: 33277607

Group type: EXPERIMENTAL
Intervention: 810 nm diode laser application as an adjunct to non-surgical periodontal therapy (NPT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-surgical periodontal therapy (NPT) without diode laser
Number of subjects: 25
Study: 36062762

Group type: EXPERIMENTAL
Intervention: Delta radiomics based on dual-energy computed tomography (DECT) images
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Optimal radiomics signature (RS) from the delta model
Number of subjects: 103
Study: 32681350

Group type: EXPERIMENTAL
Intervention: Urinary catheter valve
Number of subjects: 97

Group type: COMPARATOR
Intervention: Continuous bladder drainage
Number of subjects: 97
Study: 33026937

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 804
Study: 32591590

Group type: EXPERIMENTAL
Intervention: mCIMT + AOT (n=20)
Number of subjects: 36

Group type: COMPARATOR
Intervention: mCIMT + placebo (n=16)
Number of subjects: 36
Study: 36345020

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (ESWT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham extracorporeal shock wave therapy (sham‐ESWT)
Number of subjects: 38
Study: 33506306

Group type: EXPERIMENTAL
Intervention: Text message plus HIV self-testing (HIVST) service (n=250)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Standard of care arm (text message promoting HIV testing every 3 months) (n=241)
Number of subjects: 491
Study: 33379551

Group type: EXPERIMENTAL
Intervention: Randomized probe imaging (RPI) using visible light
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized probe imaging (RPI) using soft X-rays
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized probe imaging (RPI)
Number of subjects: 0
Study: 70651249

Group type: EXPERIMENTAL
Intervention: Prophylactic retention suture
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (running looped #1 Nylon suture)
Number of subjects: 300
Study: 35162339

Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride (YHM; 2.5 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PL; gluten-free corn starch)
Number of subjects: 18
Study: 33414482

Group type: EXPERIMENTAL
Intervention: Nilotinib 300 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imatinib 400 mg QD
Number of subjects: 0
Study: 32678438

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 34817542

Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention
Number of subjects: 349

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 349
Study: 33184024

Group type: EXPERIMENTAL
Intervention: ICS + LABA
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: ICS + LABA + LAMA
Number of subjects: 303
Study: 32167483

Group type: EXPERIMENTAL
Intervention: PainCoach app
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: PainCoach app (active use subgroup)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 71
Study: 32852242

Group type: EXPERIMENTAL
Intervention: CAST‐6 screening test
Number of subjects: 3000
Study: 33036995

Group type: EXPERIMENTAL
Intervention: Load management intervention based on ACWR principles for 10 months
Number of subjects: 482

Group type: COMPARATOR
Intervention: Control group (normal training planning)
Number of subjects: 482
Study: 32192595

Group type: EXPERIMENTAL
Intervention: Dienogest (1 mg/day, orally)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94